Professional Documents
Culture Documents
ABSTRACT
Brazil is the second largest cocaine consumer market in the world, accounting
for 20% of world drug consumption. Crack-cocaine is the consumed form of cocaine
most performance in the country.1,2 The Brazilian Northeast region has the highest crack
consumption in the country with 39% (148.000) of its users. 2 The use of crack-cocaine
has become more popular over the past 15 years especially for its lower price and its
individual and the psychoactive substance. The beginning of the consumption can be for
many reasons, which probably persist after the dependence installed. However the
diagnostics for its private psychologists and physics symptoms can enforce the
economic and social problems and increase the morbid and mortality index. 5 In the
due to substances use and mental disorders. Psychoactive substance abuse is the most
reflected in the associated terminology, which seems to change every time professional
and government committees meet to discuss the issue. One of the difficulties is how to
name disorders made by substances that change brain function. In Brazil, to classify
disorders resulting from substance use, are adopted concepts of major international
(ICD-10).10
The question of abuse of drugs has been treated predominantly in the biomedical
perspective, centered on the disease and the cure. However, social, psychological,
economic and political implications are evident and should be considered in the overall
understanding of the problem. Society culturally isolates drug users causing that many
of them do not share the expectation and desire for abstinence with health professionals
and do not even seek treatment because they do not feel accepted in their differences.11
There is currently, in Brazil, a concern in studying the profile of the crack user
population that accesses health services. Cross-sectional studies that are directed to this
clientele are important as they observe the increased demand for treatment of crack
Assistance to drug users in the Unified Health System (SUS) has the
Psychosocial Attention Centers for Alcohol and Drugs (CAPsAD) as a reference. 11 The
CAPsAD ensure the provision of specialized care close to where the users live but there
have been reported problems of access and stigmatization evidence in connection with
CAPsAD.15 A higher number of drug users, greater social visibility and higher demand
on health services lead to need for expansion of this field of study. Action planning in
this area depends on greater ownership of data about crack-cocaine users’ population
seeking treatment in public health system. Solving studies of services must be preceded
by the recognition profile of the population that will reach services. Any selectivity
METHOD
The research database “Between rocks and shots: user profiles, consumption
strategies, and social impact of crack cocaine” was consulted to establish the areas of
crack cocaine consumption in the city of Recife.17 This research included a survey of
drug users and medical records who were in care at Psychosocial Attention Centers for
Alcohol and Drugs (CAPsAD), between July 2010 and June 2011. These drug user
treatment and rehabilitation centers are maintained by the government, with public free
access. A protocol containing 38 questions was filled based on medical charts data of
parameters used for analysis were: age, gender, educational level, work condition,
duration and frequency of drug use, diagnosed psychiatric disorders as ICD-10 and
variables, confidence interval 95% and significant correlations considered when p <
0.05. Cluster analysis performed to establish correlations between main drugs used in
combination with crack-cocaine happen when multiple drug use and correlations
between diagnosed psychiatric disorders and when there was more than one disorder per
patient. Some data were not filled in database. When these situations occurred, the
database was marked as IGN (unknown). This is mainly because patient records are not
Of the 1,957 patients that seek treatment 885 (45%) were due to use of crack-
cocaine. The mean duration of drug use is 6.1±4.6 years with a minimum use of 1 year
patients.
The mean age of patients was 29.8±9.4 years; 80.3% are male; 45.6% had not
completed the 1st-9th grade; and 52% was unemployed and/or seeking for job. There are
significant correlation between 1st-9th grade incomplete education level with 27.8 years
age (p = 0.04), unemployed and/or seeking for job work condition (p = 0.01) and male
gender (p = 0.001). Unemployed and/or seeking for job work condition and 30.07 years
age also shows significant correlation (p = 0.03). Table 2 shows the main psychiatric
For the 885 crack-cocaine patients, 763 are chemical dependence of cocaine or
other drug. All psychiatric disorders were significantly correlated to each one (p <
0.04), except neurotic disorders with mood disorders (p = 0.1). It was established a
relationship between socio-economic data and psychiatric disorders, where gender, age,
education level, work condition are significant correlated with all psychiatric disorders
(p < 0.05), except age with chemical dependence (p = 0.08) and neurotic disorders (p =
0.07). Gender and personality disorders also show low significant correlation (p = 0.06),
Table 3 – Crack-cocaine use and main drugs used in combination with crack cocaine in
patients in CAPsAD.
Substance Participants
Crack (only) 64
Crack + Alcohol 45
Crack + Tobacco 24
Crack + Marijuana 65
Crack + Cocaine 6
Crack + Inhalants 2
Crack + Alcohol + Tobacco 32
Crack + Alcohol + Marijuana 85
Crack + Alcohol + Inhalants 5
Crack + Tobacco + Marijuana 63
Crack + Tobacco + Cocaine 1
Crack + Marijuana + Cocaine 10
Crack + Alcohol + Tobacco + Marijuana 183
Crack + Alcohol + Marijuana + Cocaine + Amphetamines 7
Crack + Alcohol + Tobacco + Marijuana + Benzodiazepines 18
Crack + Alcohol + Tobacco + Marijuana + Cocaine + Amphetamines + Others 2
Crack + Alcohol + Tobacco + Marijuana + Cocaine + Benzodiazepines + Others 4
Crack + Alcohol + Marijuana + Cocaine + Amphetamines + Benzodiazepines + 1
Others*
*Medical drugs; Hallucinogens.
Regarding crack-cocaine use, 64 patients used only the drug and all the others
patients used at least one drug in combination with crack-cocaine. Most part of patients
(183) used in combination crack-cocaine, alcohol, tobacco and marijuana. It was not
found crack-cocaine, cocaine and alcohol used in combination. Figure 1a shows the
cluster analysis correlating drugs used in combination with crack-cocaine and Figure 2b
A lc o h o l
C h e m ic a l d e p e n d e n c e
M a r iju a n a
M o o d d is o r d e r s
T obacco
A m p h e t a m in e s N e u r o t ic d is o r d e r s
B e n z o d ia z e p in e s P e r s o n a lit y d is o r d e r s
O th e rs
S c h iz o p h r e n ia s
C o c a in e
O th ers
I n h a la n t s
2 4 6 8 10 12 14 16 18 20 22 0 5 10 15 20 25 30
(a) L in k a g e D is t a n c e (b) L in k a g e D is t a n c e
0.04). Table 4 shows the correlation between mental disorders and use of substance in
DISCUSSION
similar to data found in national surveys.2,3 However the average age 29.8 (9.4) is
slightly higher compared to the national average which is between 18-24 years in
capitals.3
Studies typically show drug use in early adolescence. 17,18 The early use is
associated with several factors as a way to enter in a group 19, curiosity20 and problems
like lack of prospects21 and family breakdown.22 Continued use may trigger chemical
compulsive use.23,24 Nevertheless the average time of drug use being 6.1±4.6 years
shows a long survival when compared with studies showing average lifespan of people
and with approximately 30% of patients with some fixed income, this may demonstrate
a use pattern which does not directly interfere in their personal and work relationships.
Most patients have showed chemical dependence to cocaine or other drugs.
everyone should introduce some kind of mental disorder. That did not happen due to
All psychiatric disorders were significant correlated to each one (p < 0.04),
except neurotic disorders with mood disorders (p = 0.1). The pressure of society over
the individual makes the person search for forms of relaxation and possibly seek drugs
dissociation caused by way of life associated with use of drug can lead to formation of
disorders were diagnosed in women (66,7%). Despite men are more impulsive in
relation to women28, there is a higher proportion of women than men suffering from
personality disorder29. Use of crack-cocaine due to its excitatory effects can cause
borderline or antisocial conduct frames in women. 30,31 These situations are normally
report tobacco main use in conjunction (92%)3, in this study the main multiuse consists
and tobacco together with the crack-cocaine is reported as a way to reduce crack-
a way to prolong the drug effects. 33 This pattern of use can be related to a form of
prolonging the effects of crack-cocaine while their cracking effects are reduced, which
may explain the average time of use. Although it has been reported the use in
craving.34
association with chemical dependence (p = 0.01). Possibly due to other drugs increasing
cocaine effects favor installation of dependence.35 The use of alcohol and crack-cocaine
together also showed a strong association with mood disorders (p = 0.01). Probably
their use together leads to formation of cocaethylene, which has a longer half-life time
compared to cocaine33 and, due to its excitatory effects, can cause manic episodes 36 or
after the use of the amount of excitatory neurotransmitters, particularly dopamine and
noradrenalin, become reduced it can also cause depression episodes. 37 The use of
tobacco and crack-cocaine has great association with schizophrenia. Probably because
they are both excitatory drugs potentially triggering schizotypal or paranoid frames.38
Data from this study showed strong associations between crack-cocaine uses
cocaine dependence be the primary disorder treated, patient who develops associated
disorder, if not properly treated, can lead to recurrence frames. Social aspects should
also be taken into account because they are often the drug use triggers and also the
reason to keep using. Public services such as CAPsAD should be easily accessible to
population and priority on governments to ensure better treatment to those who need
ACKNOWLEDGEMENTS
National Council of scientific and technological development (CNPq) for
financial support. Study Group on Alcohol and other Drugs (GEAD) for database
consult.
DISCLOSURE
1. Louzã MRN, Hélio E. Psiquiatria básica. 2ª. Porto Alegre : Artmed, 2007.
3. Bastos FI, Bertoni N. Pesquina Nacional sobre o uso de Crack. 2014. [cited 2015 Jun
20] Available from: http://www.icict.fiocruz.br/sites/www.icict.fiocruz.br/files/Pesquisa
%20Nacional%20sobre%20o%20Uso%20de%20Crack.pdf.
4. United Nations. World Drug Report 2014. [cited 2015 Jun 20] Available from:
http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf.
10. Zaleski M, Laranjeira RR, Marques ACPR, Ratto L, Romano M, Alves HNP,
Soares MBM, Abelardino V, Kessler F, Brasiliano S, Nicastri S, Hochgraf PB, Gigliotti
AP, Lemos T. Diretrizes da associação brasileira de estudos do álcool e outras drogas
(ABEAD) para o diagnóstico e tratamento de comorbidades psiquiátricas dependência
de álcool e outras substâncias. Revista Brasileira de Psiquiatria. 2006, Vol. 28, 2, pp.
142-148.
12. Parry CDH, Plüddemann A, Myers BJ. Cocaine treatment admissions at three
sentinel sites in South Africa (1997-2006): findings and implications for policy, practice
and research. Subst Abuse Treat Prev Policy. 2007, Vol. 2, 37, pp. 1-8.
13. Schifano F, Corkery J. Cocaine/crack cocaine consumption, treatment demand,
seizures, related offences, prices, average purity levels and deaths in the UK (1990 -
2004). J Psychopharmacol. 2008, Vol. 22, 1, pp. 71-79.
14. Borini P, Guimarães RC, Borini SB. Usuários de drogas ilícitas internados em
hospital psiquiátrico: padrões de uso e aspectos demográficos e epidemiológicos. J Bras
Psiquiatr. 2003, Vol. 52, 3, pp. 171-179.
15. Duailibi LB, Laranjeira R, Ribeiro M. Profile of cocaine and crack users in Brazil.
Cad Saúde Pública. 2008, Vol. 24, 4, pp. 545-557.
16. Horta RL, Horta BL, Rosset AP, Horta CL. Perfil dos usuários de crack que buscam
atendimento em Centros de Atenção Psicossocial. Cad. Saúde Pública. 2011, Vol. 27,
11, pp. 2263-2270.
17. Chaney RA, Rojas-Guyler L. Spatial patterns of adolescent drug use. Applied
Geography. 2015, Vol. 56, pp. 71–82.
18. Brière FN, Fallu JS, Morizot J, Janosz M. Adolescent illicit drug use and subsequent
academic and psychosocial adjustment: An examination of socially-mediated pathways.
Drug and Alcohol Dependence. 2014, Vol. 135, 1, pp. 45–51.
19. Barber JG, Bolitho F, Bertrand LD. Intrapersonal versus peer group predictors of
adolescent drug use. Children and Youth Services Review. 1999, Vol. 21, 7, pp. 565–
579.
20. Nodora J, Hartman SJ, Strong DR, Messer K, Vera LE, White MM, Portnoy DB,
Choiniere CJ, Vullo GC, Pierce JP. Curiosity predicts smoking experimentation
independent of susceptibility in a US national sample. Addictive Behaviors. 2014, Vol.
39, 13, pp. 1695–1700.
21. Arria AM, Garnier-Dykstra LM, Cook ET, Caldeira KM, Vincent KB, Baron RA,
O’grady KE. Drug use patterns in young adulthood and post-college employment. Drug
Alcohol Dependence. 2013, Vol. 127, 1-3, pp. 23-30.
22. Salas-Wright CP, Vaughn MG, Hodge DR, Perron BE. Religiosity Profiles of
American Youth in Relation to Substance Use, Violence, and Delinquency. Journal of
Youth and Adolescence. 2012, Vol. 41, 12, pp. 1560-1575.
23. Kuhns JB, Clodfelter TA. Illicit drug-related psychopharmacological violence: The
current understanding within a causal context. Aggression and Violent Behavior. 2009,
Vol. 14, 1, pp. 69–78.
24. Reed E, Raj A, Falbo G, Caminha F, Decker MR, Kaliel DC, Missmer A, Molnar
BE, Silverman JG. The prevalence of violence and relation to depression and illicit drug
use among incarcerated women in Recife, Brazil. International Journal of Law and
Psychiatry. 2009, Vol. 32, 5, pp. 323–328.
25. EV, Aston. Are risk factors for drug use and offending similar during the teenage
years? International Journal of Drug Policy. 2015, Vol. 26, 4, pp. 396–403.
26. Palmer RHC, Knopik VS, Rhee SH, Hopfer CJ, Corley RC, Young SE, Stallings
MC, Hewitt JK. Prospective effects of adolescent indicators of behavioral disinhibition
on DSM-IV alcohol, tobacco, and illicit drug dependence in young adulthood.
Addictive Behaviors. 2013, Vol. 38, 9, pp. 2415–2421.
28. Weafer J, Wit H. Sex differences in impulsive action and impulsive choice.
Addictive Behaviors. 2014, Vol. 39, 11, pp. 1573–1579.
29. Sansone RA, Sansone LA. Gender Patterns in Borderline Personality Disorder.
Innovations in Clinical Neurosciences. 2011, Vol. 8, 5, pp. 16–20.
30. Grella CE, Joshi V, Hser YI. Followup of cocaine-dependent men and women with
antisocial personality disorder. Journal of Substance Abuse Treatment. 2003, Vol. 25, 3,
pp. 155–164.
31. Bardeena JR, Dixon-Gordonb KL, Tullb MT, Lyonsc JA, Gratz KL. An
investigation of the relationship between borderline personality disorder and cocaine-
related attentional bias following trauma cue exposure: The moderating role of gender.
Comprehensive Psychiatry. 2014, Vol. 55, 1, pp. 113–122.
32. Chaves TV, Sanchez ZM, Ribeiro LA, Nappo SA. Crack cocaine craving: behaviors
and coping strategies among current and former users. Revista de Saúde Pública. 2011,
Vol. 45, 6, pp. 1168-1175.
33. Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene
in humans following cocaine and ethanol administration. Drug and Alcohol
Dependence. 2003, Vol. 72, 2, pp. 169–182.
34. Fox HC, Talih M, Malison R, Andersom GM, Kreek MJ, Sinha R. Frequency of
recent cocaine and alcohol use affects drug craving and associated responses to stress
and drug-related cues. Psychoneuroendocrinology. 2005, Vol. 30, 9, pp. 880–891.
38. Moreno RA, Moreno DH, Ratzke R. Diagnosis, Treatment and Prevention of Mania
and Hipomania within the Bipolar Disorder. Revista de Psiquiatria Clínica. 2005, Vol.
32, 1, pp. 39-48.
37. Mansari M, Guiard BP, Chernoloz O, Ghanbari R, Katz N, Blier P. Relevance of
Norepinephrine–Dopamine Interactions in the Treatment of Major Depressive Disorder.
CNS Neuroscience Therapeutics. 2010, Vol. 16, 3, pp. 1-17.